MARLBOROUGH, Massachusetts, Jan. 9, 2018 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) today announced it has obtained a CE Mark in Europe for the Brevera ® breast biopsy system with CorLumina ® ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Aug 31 (Reuters) - Hologic Inc: * Hologic inc - U.S. commercial availability of Brevera Breast Biopsy System with Corlumina imaging technology Source text for Eikon: Further company coverage: ...
Stereotactic breast biopsy needles have recently been placed on the medical device shortage list by FDA. The shortage could negatively impact Hologic, a company ranked 29th on MD+DI ’s Top 100 Medical ...
BioWorld - Friday, December 29, 2023 See today's BioWorld MedTech Home » Hologic's Brevera biopsy system hits U.S. market Upgrade your daily dose of biopharma and medtech news Subscribe to BioWorld™ ...
Hologic, Inc. HOLX recently announced the addition of improved features to its Brevera Breast Biopsy System with CorLumina Imaging Technology. Notably, the system was launched in 2017 and has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results